Fondaparinux Sodium (Dr. Reddy’s Laboratories Inc.)


Welcome to the PulseAid listing for the Fondaparinux Sodium drug offered from Dr. Reddy’s Laboratories Inc.. This Factor Xa Inhibitor [EPC],Factor Xa Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Dr. Reddy’s Laboratories Inc.
NON-PROPRIETARY NAME: Fondaparinux Sodium
SUBSTANCE NAME: FONDAPARINUX SODIUM
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Factor Xa Inhibitor [EPC],Factor Xa Inhibitors [MoA]
ROUTE: SUBCUTANEOUS
DOSAGE FORM: INJECTION
MARKETING CATEGORY NAME: ANDA
START MARKETING DATE: 2017-07-27
END MARKETING DATE: 0000-00-00


Fondaparinux Sodium HUMAN PRESCRIPTION DRUG Details:

Item DescriptionFondaparinux Sodium from Dr. Reddy’s Laboratories Inc.
LABELER NAME: Dr. Reddy’s Laboratories Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 10(mg/.8mL)
START MARKETING DATE: 2017-07-27
END MARKETING DATE: 0000-00-00
PRODUCT ID: 43598-606_d8df1384-a587-0531-3416-25a63201409d
PRODUCT NDC: 43598-606
APPLICATION NUMBER: ANDA091316

Other FONDAPARINUX SODIUM Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Dr. Reddy’s Laboratories Inc.Fondaparinux Sodium
Dr. Reddy’s Laboratories LimitedFondaparinux Sodium
Mylan Institutional LLCFondaparinux Sodium
Physicians Total Care, Inc.ARIXTRA